Suzhou, China

Xinyong Lv

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Suzhou, CN (2019 - 2023)
  • Jiangsu, CN (2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Xinyong Lv: Innovator in Pharmaceutical Chemistry

Introduction

Xinyong Lv is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 7 patents to his name, his work focuses on innovative solutions for treating complex diseases.

Latest Patents

Among his latest patents is the invention of isotope-enriched 3-amino-1-propanesulfonic acid derivatives and their uses. This invention provides isotope-enriched compounds of Formula (I) and pharmaceutically acceptable salts or esters, along with pharmaceutical compositions and methods for preventing and treating amyloid-β related diseases, such as Alzheimer's disease. Another notable patent is the crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acid, which details the preparation method and various uses of this compound.

Career Highlights

Xinyong Lv is currently associated with Risen (Suzhou) Pharma Tech Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the understanding and treatment of neurodegenerative diseases.

Collaborations

He has collaborated with notable colleagues, including Jiasheng Lu and Jiamin Gu, to further enhance the impact of his research and innovations in the pharmaceutical industry.

Conclusion

Xinyong Lv's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing effective treatments for serious health conditions. His ongoing research and patents continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…